vs

Side-by-side financial comparison of Sprinklr, Inc. (CXM) and Sotera Health Co (SHC). Click either name above to swap in a different company.

Sotera Health Co is the larger business by last-quarter revenue ($303.4M vs $219.1M, roughly 1.4× Sprinklr, Inc.). Sotera Health Co runs the higher net margin — 11.5% vs 1.3%, a 10.2% gap on every dollar of revenue. On growth, Sprinklr, Inc. posted the faster year-over-year revenue change (9.2% vs 4.6%). Sotera Health Co produced more free cash flow last quarter ($52.4M vs $19.8M). Over the past eight quarters, Sotera Health Co's revenue compounded faster (10.6% CAGR vs 6.2%).

Sprinklr is an American software company that develops a software as a service (SaaS) customer experience management (CXM) platform. The company's software, also called Sprinklr, combines different applications for social media marketing, social advertising, content management, collaboration, employee advocacy, customer care, social media research, and social media monitoring.

Sotera Health Co is a global provider of end-to-end medical safety solutions. It offers sterilization services, analytical laboratory testing, and regulatory advisory support for medical device manufacturers, pharmaceutical firms, and food and consumer product companies, helping clients meet industry standards and ensure product safety for end users worldwide.

CXM vs SHC — Head-to-Head

Bigger by revenue
SHC
SHC
1.4× larger
SHC
$303.4M
$219.1M
CXM
Growing faster (revenue YoY)
CXM
CXM
+4.6% gap
CXM
9.2%
4.6%
SHC
Higher net margin
SHC
SHC
10.2% more per $
SHC
11.5%
1.3%
CXM
More free cash flow
SHC
SHC
$32.6M more FCF
SHC
$52.4M
$19.8M
CXM
Faster 2-yr revenue CAGR
SHC
SHC
Annualised
SHC
10.6%
6.2%
CXM

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
CXM
CXM
SHC
SHC
Revenue
$219.1M
$303.4M
Net Profit
$2.9M
$34.8M
Gross Margin
66.4%
54.7%
Operating Margin
5.3%
23.2%
Net Margin
1.3%
11.5%
Revenue YoY
9.2%
4.6%
Net Profit YoY
-72.2%
182.8%
EPS (diluted)
$0.01
$0.12

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CXM
CXM
SHC
SHC
Q4 25
$219.1M
$303.4M
Q3 25
$212.0M
$311.3M
Q2 25
$205.5M
$294.3M
Q1 25
$202.5M
$254.5M
Q4 24
$200.7M
$290.2M
Q3 24
$197.2M
$285.5M
Q2 24
$196.0M
$276.6M
Q1 24
$194.2M
$248.2M
Net Profit
CXM
CXM
SHC
SHC
Q4 25
$2.9M
$34.8M
Q3 25
$12.6M
$48.4M
Q2 25
$-1.6M
$8.0M
Q1 25
$98.7M
$-13.3M
Q4 24
$10.5M
$12.3M
Q3 24
$1.8M
$17.0M
Q2 24
$10.6M
$8.8M
Q1 24
$21.1M
$6.3M
Gross Margin
CXM
CXM
SHC
SHC
Q4 25
66.4%
54.7%
Q3 25
68.2%
57.0%
Q2 25
69.5%
56.6%
Q1 25
71.0%
53.2%
Q4 24
71.2%
56.6%
Q3 24
72.6%
55.4%
Q2 24
73.9%
55.2%
Q1 24
75.5%
51.2%
Operating Margin
CXM
CXM
SHC
SHC
Q4 25
5.3%
23.2%
Q3 25
7.7%
23.4%
Q2 25
-0.9%
6.4%
Q1 25
5.2%
-5.8%
Q4 24
3.9%
30.0%
Q3 24
-0.0%
28.2%
Q2 24
2.9%
27.8%
Q1 24
9.5%
21.4%
Net Margin
CXM
CXM
SHC
SHC
Q4 25
1.3%
11.5%
Q3 25
5.9%
15.5%
Q2 25
-0.8%
2.7%
Q1 25
48.7%
-5.2%
Q4 24
5.2%
4.2%
Q3 24
0.9%
6.0%
Q2 24
5.4%
3.2%
Q1 24
10.9%
2.5%
EPS (diluted)
CXM
CXM
SHC
SHC
Q4 25
$0.01
$0.12
Q3 25
$0.05
$0.17
Q2 25
$-0.01
$0.03
Q1 25
$0.35
$-0.05
Q4 24
$0.04
$0.05
Q3 24
$0.01
$0.06
Q2 24
$0.04
$0.03
Q1 24
$0.07
$0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CXM
CXM
SHC
SHC
Cash + ST InvestmentsLiquidity on hand
$189.6M
$344.6M
Total DebtLower is stronger
$2.1B
Stockholders' EquityBook value
$558.1M
$606.0M
Total Assets
$1.1B
$3.3B
Debt / EquityLower = less leverage
3.53×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CXM
CXM
SHC
SHC
Q4 25
$189.6M
$344.6M
Q3 25
$125.4M
$299.2M
Q2 25
$126.4M
$332.4M
Q1 25
$145.3M
$304.4M
Q4 24
$93.2M
$277.2M
Q3 24
$119.1M
$306.7M
Q2 24
$126.8M
$246.1M
Q1 24
$164.0M
$261.1M
Total Debt
CXM
CXM
SHC
SHC
Q4 25
$2.1B
Q3 25
$2.1B
Q2 25
$2.2B
Q1 25
$2.2B
Q4 24
$2.2B
Q3 24
$2.2B
Q2 24
$2.2B
Q1 24
$2.2B
Stockholders' Equity
CXM
CXM
SHC
SHC
Q4 25
$558.1M
$606.0M
Q3 25
$543.4M
$550.5M
Q2 25
$639.8M
$511.3M
Q1 25
$612.1M
$414.1M
Q4 24
$497.0M
$404.9M
Q3 24
$469.0M
$470.2M
Q2 24
$610.9M
$422.8M
Q1 24
$679.7M
$429.4M
Total Assets
CXM
CXM
SHC
SHC
Q4 25
$1.1B
$3.3B
Q3 25
$1.1B
$3.2B
Q2 25
$1.2B
$3.2B
Q1 25
$1.2B
$3.1B
Q4 24
$970.3M
$3.1B
Q3 24
$983.8M
$3.1B
Q2 24
$1.1B
$3.1B
Q1 24
$1.2B
$3.1B
Debt / Equity
CXM
CXM
SHC
SHC
Q4 25
3.53×
Q3 25
3.89×
Q2 25
4.34×
Q1 25
5.36×
Q4 24
5.49×
Q3 24
4.73×
Q2 24
5.26×
Q1 24
5.19×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CXM
CXM
SHC
SHC
Operating Cash FlowLast quarter
$20.0M
$103.1M
Free Cash FlowOCF − Capex
$19.8M
$52.4M
FCF MarginFCF / Revenue
9.0%
17.3%
Capex IntensityCapex / Revenue
0.1%
16.7%
Cash ConversionOCF / Net Profit
6.87×
2.96×
TTM Free Cash FlowTrailing 4 quarters
$142.3M
$149.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CXM
CXM
SHC
SHC
Q4 25
$20.0M
$103.1M
Q3 25
$34.8M
$71.2M
Q2 25
$83.8M
$57.4M
Q1 25
$5.4M
$55.5M
Q4 24
$9.2M
$55.7M
Q3 24
$21.3M
$97.5M
Q2 24
$41.7M
$61.3M
Q1 24
$17.3M
$9.7M
Free Cash Flow
CXM
CXM
SHC
SHC
Q4 25
$19.8M
$52.4M
Q3 25
$34.4M
$35.0M
Q2 25
$83.5M
$26.2M
Q1 25
$4.6M
$35.6M
Q4 24
$8.2M
$-10.2M
Q3 24
$19.8M
$61.1M
Q2 24
$39.2M
$19.4M
Q1 24
$15.2M
$-25.2M
FCF Margin
CXM
CXM
SHC
SHC
Q4 25
9.0%
17.3%
Q3 25
16.2%
11.2%
Q2 25
40.6%
8.9%
Q1 25
2.3%
14.0%
Q4 24
4.1%
-3.5%
Q3 24
10.1%
21.4%
Q2 24
20.0%
7.0%
Q1 24
7.9%
-10.2%
Capex Intensity
CXM
CXM
SHC
SHC
Q4 25
0.1%
16.7%
Q3 25
0.2%
11.6%
Q2 25
0.1%
10.6%
Q1 25
0.4%
7.8%
Q4 24
0.5%
22.7%
Q3 24
0.8%
12.7%
Q2 24
1.3%
15.2%
Q1 24
1.1%
14.1%
Cash Conversion
CXM
CXM
SHC
SHC
Q4 25
6.87×
2.96×
Q3 25
2.76×
1.47×
Q2 25
7.21×
Q1 25
0.05×
Q4 24
0.88×
4.52×
Q3 24
11.58×
5.73×
Q2 24
3.92×
7.00×
Q1 24
0.82×
1.53×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CXM
CXM

License And Service$190.3M87%
Professional Services$28.8M13%

SHC
SHC

Transferred At Point In Time$198.4M65%
Nelson Labs$55.2M18%
Nordion$49.8M16%

Related Comparisons